Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Carmela Nappi , Valeria Gaudieri , Alberto Cuocolo Added: 3 years ago
Evaluating stress-induced myocardial perfusion defects by non-invasive myocardial perfusion imaging (MPI) modalities has taken a leading role in the identification of flow-limiting epicardial coronary artery disease (CAD); it has excellent diagnostic and prognostic value. Non-invasive MPI can be performed using conventional and novel gamma cameras or PET/CT.1 A range of imaging techniques has… View more

Imaging & Diagnostics

Prevention & Chronic Conditions
Amalia Peix
Research Area(s) / Expertise: Job title: Full Professor & Senior Researcher
Overview Dr Amalia Peix was born in Havana, Cuba and has specialised in nuclear cardiology since 1991.1 She is currently an MD, Professor and Senior Researcher at the Institute of Cardiology and Cardiovascular Surgery in Havana, Cuba. Academic History 1974 – 1980: High Institute of Medical Sciences, Havana, Cuba. Career Overview Dr Peix is a member of the National PhD… View more
Author(s): Annemien E van den Bosch , Boudewijn J Krenning , Jos RTC Roelandt Added: 3 years ago
Introduction The heart is a dynamic organ and places special demands on three-dimensional (3-D) techniques. To understand its physiology and pathophysiology, not only the spatial distribution of its structures is important but also their movement during the cardiac cycles. Previous approaches to 3-D echocardiography (3-DE) were offline and based on sequential rotational scanning and acquisition… View more

Imaging & Diagnostics
Author(s): Annemien E van den Bosch , Boudewijn J Krenning , Jos RTC Roelandt Added: 3 years ago
Introduction The heart is a dynamic organ and places special demands on three-dimensional (3-D) techniques. To understand its physiology and pathophysiology, not only the spatial distribution of its structures is important but also their movement during the cardiac cycles. Previous approaches to 3-D echocardiography (3-DE) were offline and based on sequential rotational scanning and acquisition… View more

Imaging & Diagnostics
Author(s): Jose Luis Zamorano Added: 3 years ago
2D echocardiography (2DE) is a common diagnostic and treatment planning tool in clinical cardiology, especially for the assessment of left ventricular (LV) volume and function. However, traditional 2DE is severely limited by its dependence on geometrical assumptions, which can lead to inaccuracies in volume quantification.1 Because 3D echocardiographic (3DE) imaging eliminates geometrical… View more

Imaging & Diagnostics
Wrap up of ACC 2019: An Analysis of the Late-Breaking Trials
Author(s): Nicolas M Van Mieghem Added: 5 years ago
An analysis of the late-breaking trials from ACC 2019 presented by Dr Nicolas van Mieghem (Erasmus MC, Rotterdam, NL). Filmed on site at ACC 2019 by Radcliffe Cardiology Topics: 00:19 - Apple Heart Study 01:50 - PARTNER 3 Trial 03:44 - CoreValve Low Risk Study 06:26 - STS/TVT Registry Sub-Analysis 07:32 - COAPT Quality of Life Analysis 07:43 - COAPT Echo Sub-Analysis 08:14 - AUGUSTUS… View more

Heart Failure

Electrophysiology & Arrhythmia
ESC 22: EMPEROR-Preserved & DELIVER Meta-Analysis: SGLT2is in HF
Author(s): Muthiah Vaduganathan Added: 1 year ago
ESC 22 - Dr Muthiah Vaduganathan joins us on-site at ESC 2022 to discuss the findings of a prespecified meta-analysis of the EMPEROR-Preserved and DELIVER Trials, both of which aimed to evaluate the effects of SGLT2 inhibitors on patients with heart failure. Questions: 1. What were the prespecifications for this meta-analysis? 2. What was the rationale for performing a meta-analysis on these… View more

Heart Failure
HF 22: HELIOS-A: Vutrisiran in Patients with hATTR Amyloidosis
Added: 1 year ago
In this short interview, Dr Pablo Garcia-Pavia (Hospital Universitario Puerta de Hierro Majadahonda, ES) shares the findings from the phase 3 study, HELIOS-A (NCT03759379). The study, presented at Heart Failure 2022, investigated the efficacy and safety of vutrisiran (ALN-TTRSC02) in patients with hereditary transthyretin amyloidosis (hATTR amyloidosis). Discussion Points 1. Vutrisiran 3. Study… View more

Heart Failure

MI/ACS
HF 22: Findings from the Pooled Analysis of DEFINE-HF and PRESERVED-HF
Author(s): Mikhail Kosiborod Added: 1 year ago
In this short interview, Dr Mikhail Kosiborod (Saint Luke’s Mid America Heart Institute, Kansas City, US) shares the findings from the pooled analysis of DEFINE-HF and PRESERVED-HF. The study, presented first at Heart Failure 2022, showed that that dapagliflozin improved symptoms and physical limitations in patients with HF and that the benefits were highly consistent across the entire range of… View more

Heart Failure
Ranolazine to Improve Diastolic Performance
Author(s): Desak Ketut Sekar Cempaka Putri , Andrianto Andrianto , Makhyan Jibril Al-Farabi , et al Added: 1 year ago

Heart Failure